Search details
1.
Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing.
Cell
; 174(2): 433-447.e19, 2018 07 12.
Article
in English
| MEDLINE | ID: mdl-29909985
2.
Cancer aneuploidies are shaped primarily by effects on tumour fitness.
Nature
; 619(7971): 793-800, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37380777
3.
Genomic Characterization of Prostatic Basal Cell Carcinoma.
Am J Pathol
; 193(1): 4-10, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36309102
4.
Genetic and transcriptional evolution alters cancer cell line drug response.
Nature
; 560(7718): 325-330, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30089904
5.
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Prostate
; 82(5): 584-597, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35084050
6.
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.
Nature
; 518(7539): 422-6, 2015 Feb 19.
Article
in English
| MEDLINE | ID: mdl-25470049
7.
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group.
Br J Cancer
; 120(8): 869, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30880335
8.
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group.
Br J Cancer
; 119(5): 615-621, 2018 08.
Article
in English
| MEDLINE | ID: mdl-30131550
9.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Nature
; 486(7403): 346-52, 2012 Apr 18.
Article
in English
| MEDLINE | ID: mdl-22522925
10.
The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
Nature
; 486(7403): 395-9, 2012 Apr 04.
Article
in English
| MEDLINE | ID: mdl-22495314
11.
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data.
Genome Res
; 24(11): 1881-93, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25060187
12.
PyClone: statistical inference of clonal population structure in cancer.
Nat Methods
; 11(4): 396-8, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24633410
13.
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup.
Blood
; 125(6): 959-66, 2015 Feb 05.
Article
in English
| MEDLINE | ID: mdl-25395426
14.
Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden.
J Pathol
; 236(2): 201-9, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25692284
15.
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
N Engl J Med
; 366(3): 234-42, 2012 Jan 19.
Article
in English
| MEDLINE | ID: mdl-22187960
16.
Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer.
Genome Res
; 22(10): 1995-2007, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22637570
17.
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profiling.
J Pathol
; 231(1): 21-34, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23780408
18.
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA.
bioRxiv
; 2024 Jan 02.
Article
in English
| MEDLINE | ID: mdl-38260558
19.
Assay Validation of Cell-Free DNA Shallow Whole-Genome Sequencing to Determine Tumor Fraction in Advanced Cancers.
J Mol Diagn
; 26(5): 413-422, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38490303
20.
Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regions.
Sci Adv
; 10(15): eadk2082, 2024 Apr 12.
Article
in English
| MEDLINE | ID: mdl-38598634